Global Tumor Registry Software Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI04242981

Publication Date:

April 19, 2024

Pages:

114

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

IT Services [2]

Software [3]

Computing & Electronics [4]

Description:

The global Tumor Registry Software market size is projected to grow from US$ 824 million in 2023 to US$ 1478.8 million in 2030; it is expected to grow at a CAGR of 8.7% from 2024 to 2030.
The 鈥淭umor Registry Software Industry Forecast鈥� looks at past sales and reviews total world Tumor Registry Software sales in 2023, providing a comprehensive analysis by region and market sector of projected Tumor Registry Software sales for 2024 through 2030. With Tumor Registry Software sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tumor Registry Software industry.
This Insight Report provides a comprehensive analysis of the global Tumor Registry Software landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Tumor Registry Software portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Tumor Registry Software market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tumor Registry Software and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tumor Registry Software.
The healthcare industry, including tumor registries, is experiencing a shift towards electronic health records. Tumor registry software is being integrated with EHR systems for seamless data sharing and improved interoperability.Focus on Interoperability and Data Exchange:Interoperability remains a significant trend in tumor registry software. Efforts are being made to enhance the exchange of cancer-related data among different healthcare systems and organizations, facilitating comprehensive patient care and research.Implementation of Cancer Staging and Reporting Standards:Tumor registry software is aligning with standardized cancer staging and reporting systems. Compliance with international standards ensures consistency in data collection, analysis, and reporting, supporting collaboration in cancer research and treatment.
This report presents a comprehensive overview, market shares, and growth opportunities of Tumor Registry Software market by product type, application, key players and key regions and countries.
Segmentation by type
On Premise
Cloud Based
Segmentation by application
Government and Third Party
Hospital and Medical Practice
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
C/NET Solutions
Conduent Inc.
Electronic Registry System Inc.
Elekta
Himagine solutions
IBM Corporation
McKesson Corporation
NeuralFrame,Inc.
Onco Inc.
Ordinal Data Inc.
Rocky Mountain Cancer Data Systems

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Tumor Registry Software Market Size 2019-2030
2.1.2 Tumor Registry Software Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Tumor Registry Software Segment by Type
2.2.1 On Premise
2.2.2 Cloud Based
2.3 Tumor Registry Software Market Size by Type
2.3.1 Tumor Registry Software Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Tumor Registry Software Market Size Market Share by Type (2019-2024)
2.4 Tumor Registry Software Segment by Application
2.4.1 Government and Third Party
2.4.2 Hospital and Medical Practice
2.4.3 Others
2.5 Tumor Registry Software Market Size by Application
2.5.1 Tumor Registry Software Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Tumor Registry Software Market Size Market Share by Application (2019-2024)
3 Tumor Registry Software Market Size by Player
3.1 Tumor Registry Software Market Size Market Share by Players
3.1.1 Global Tumor Registry Software Revenue by Players (2019-2024)
3.1.2 Global Tumor Registry Software Revenue Market Share by Players (2019-2024)
3.2 Global Tumor Registry Software Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Tumor Registry Software by Regions
4.1 Tumor Registry Software Market Size by Regions (2019-2024)
4.2 Americas Tumor Registry Software Market Size Growth (2019-2024)
4.3 APAC Tumor Registry Software Market Size Growth (2019-2024)
4.4 Europe Tumor Registry Software Market Size Growth (2019-2024)
4.5 Middle East & Africa Tumor Registry Software Market Size Growth (2019-2024)
5 Americas
5.1 Americas Tumor Registry Software Market Size by Country (2019-2024)
5.2 Americas Tumor Registry Software Market Size by Type (2019-2024)
5.3 Americas Tumor Registry Software Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Tumor Registry Software Market Size by Region (2019-2024)
6.2 APAC Tumor Registry Software Market Size by Type (2019-2024)
6.3 APAC Tumor Registry Software Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Tumor Registry Software by Country (2019-2024)
7.2 Europe Tumor Registry Software Market Size by Type (2019-2024)
7.3 Europe Tumor Registry Software Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Tumor Registry Software by Region (2019-2024)
8.2 Middle East & Africa Tumor Registry Software Market Size by Type (2019-2024)
8.3 Middle East & Africa Tumor Registry Software Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Tumor Registry Software Market Forecast
10.1 Global Tumor Registry Software Forecast by Regions (2025-2030)
10.1.1 Global Tumor Registry Software Forecast by Regions (2025-2030)
10.1.2 Americas Tumor Registry Software Forecast
10.1.3 APAC Tumor Registry Software Forecast
10.1.4 Europe Tumor Registry Software Forecast
10.1.5 Middle East & Africa Tumor Registry Software Forecast
10.2 Americas Tumor Registry Software Forecast by Country (2025-2030)
10.2.1 United States Tumor Registry Software Market Forecast
10.2.2 Canada Tumor Registry Software Market Forecast
10.2.3 Mexico Tumor Registry Software Market Forecast
10.2.4 Brazil Tumor Registry Software Market Forecast
10.3 APAC Tumor Registry Software Forecast by Region (2025-2030)
10.3.1 China Tumor Registry Software Market Forecast
10.3.2 Japan Tumor Registry Software Market Forecast
10.3.3 Korea Tumor Registry Software Market Forecast
10.3.4 Southeast Asia Tumor Registry Software Market Forecast
10.3.5 India Tumor Registry Software Market Forecast
10.3.6 Australia Tumor Registry Software Market Forecast
10.4 Europe Tumor Registry Software Forecast by Country (2025-2030)
10.4.1 Germany Tumor Registry Software Market Forecast
10.4.2 France Tumor Registry Software Market Forecast
10.4.3 UK Tumor Registry Software Market Forecast
10.4.4 Italy Tumor Registry Software Market Forecast
10.4.5 Russia Tumor Registry Software Market Forecast
10.5 Middle East & Africa Tumor Registry Software Forecast by Region (2025-2030)
10.5.1 Egypt Tumor Registry Software Market Forecast
10.5.2 South Africa Tumor Registry Software Market Forecast
10.5.3 Israel Tumor Registry Software Market Forecast
10.5.4 Turkey Tumor Registry Software Market Forecast
10.5.5 GCC Countries Tumor Registry Software Market Forecast
10.6 Global Tumor Registry Software Forecast by Type (2025-2030)
10.7 Global Tumor Registry Software Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 C/NET Solutions
11.1.1 C/NET Solutions Company Information
11.1.2 C/NET Solutions Tumor Registry Software Product Offered
11.1.3 C/NET Solutions Tumor Registry Software Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 C/NET Solutions Main Business Overview
11.1.5 C/NET Solutions Latest Developments
11.2 Conduent Inc.
11.2.1 Conduent Inc. Company Information
11.2.2 Conduent Inc. Tumor Registry Software Product Offered
11.2.3 Conduent Inc. Tumor Registry Software Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Conduent Inc. Main Business Overview
11.2.5 Conduent Inc. Latest Developments
11.3 Electronic Registry System Inc.
11.3.1 Electronic Registry System Inc. Company Information
11.3.2 Electronic Registry System Inc. Tumor Registry Software Product Offered
11.3.3 Electronic Registry System Inc. Tumor Registry Software Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Electronic Registry System Inc. Main Business Overview
11.3.5 Electronic Registry System Inc. Latest Developments
11.4 Elekta
11.4.1 Elekta Company Information
11.4.2 Elekta Tumor Registry Software Product Offered
11.4.3 Elekta Tumor Registry Software Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Elekta Main Business Overview
11.4.5 Elekta Latest Developments
11.5 Himagine solutions
11.5.1 Himagine solutions Company Information
11.5.2 Himagine solutions Tumor Registry Software Product Offered
11.5.3 Himagine solutions Tumor Registry Software Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Himagine solutions Main Business Overview
11.5.5 Himagine solutions Latest Developments
11.6 IBM Corporation
11.6.1 IBM Corporation Company Information
11.6.2 IBM Corporation Tumor Registry Software Product Offered
11.6.3 IBM Corporation Tumor Registry Software Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 IBM Corporation Main Business Overview
11.6.5 IBM Corporation Latest Developments
11.7 McKesson Corporation
11.7.1 McKesson Corporation Company Information
11.7.2 McKesson Corporation Tumor Registry Software Product Offered
11.7.3 McKesson Corporation Tumor Registry Software Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 McKesson Corporation Main Business Overview
11.7.5 McKesson Corporation Latest Developments
11.8 NeuralFrame,Inc.
11.8.1 NeuralFrame,Inc. Company Information
11.8.2 NeuralFrame,Inc. Tumor Registry Software Product Offered
11.8.3 NeuralFrame,Inc. Tumor Registry Software Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 NeuralFrame,Inc. Main Business Overview
11.8.5 NeuralFrame,Inc. Latest Developments
11.9 Onco Inc.
11.9.1 Onco Inc. Company Information
11.9.2 Onco Inc. Tumor Registry Software Product Offered
11.9.3 Onco Inc. Tumor Registry Software Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Onco Inc. Main Business Overview
11.9.5 Onco Inc. Latest Developments
11.10 Ordinal Data Inc.
11.10.1 Ordinal Data Inc. Company Information
11.10.2 Ordinal Data Inc. Tumor Registry Software Product Offered
11.10.3 Ordinal Data Inc. Tumor Registry Software Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Ordinal Data Inc. Main Business Overview
11.10.5 Ordinal Data Inc. Latest Developments
11.11 Rocky Mountain Cancer Data Systems
11.11.1 Rocky Mountain Cancer Data Systems Company Information
11.11.2 Rocky Mountain Cancer Data Systems Tumor Registry Software Product Offered
11.11.3 Rocky Mountain Cancer Data Systems Tumor Registry Software Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Rocky Mountain Cancer Data Systems Main Business Overview
11.11.5 Rocky Mountain Cancer Data Systems Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂